Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Treasury Shares (2018 - 2025)

Catheter Precision has reported Treasury Shares over the past 7 years, most recently at $6000.0 for Q3 2025.

  • Quarterly Treasury Shares changed N/A to $6000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $61.0 for FY2022, 95.65% down from the prior year.
  • Treasury Shares was $6000.0 for Q3 2025 at Catheter Precision, down from $50001.0 in the prior quarter.
  • Over five years, Treasury Shares peaked at $753.7 million in Q3 2023 and troughed at $26.0 in Q2 2023.
  • The 4-year median for Treasury Shares is $47734.0 (2021), against an average of $62.9 million.
  • Year-over-year, Treasury Shares tumbled 98.0% in 2021 and then surged 55664523.34% in 2023.
  • A 4-year view of Treasury Shares shows it stood at $1402.0 in 2021, then tumbled by 95.65% to $61.0 in 2022, then surged by 1235572031.15% to $753.7 million in 2023, then tumbled by 100.0% to $6000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Treasury Shares are $6000.0 (Q3 2025), $50001.0 (Q1 2025), and $753.7 million (Q3 2023).